Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
Purpose: To investigate the incidence and risk factors associated with persistent urinary frequency, and to evaluate the efficacy of antimuscarinic treatment.Materials and Methods: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients complaining of persistent urinary frequency despite impro...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2017-09-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-58-353.pdf |
id |
doaj-90f3ac0908af42769a8b8ead0c213124 |
---|---|
record_format |
Article |
spelling |
doaj-90f3ac0908af42769a8b8ead0c2131242020-11-24T21:00:28ZengKorean Urological AssociationInvestigative and Clinical Urology2466-04932466-054X2017-09-0158535335810.4111/icu.2017.58.5.353Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatmentAram Kim0Kyeong-Ok Hoe1Jung Hyun Shin2Myung-Soo Choo3Konkuk University School of Medicine, Seoul, KoreaAsan Medical Center, Seoul, KoreaAsan Medical Center, Seoul, KoreaAsan Medical Center, Seoul, KoreaPurpose: To investigate the incidence and risk factors associated with persistent urinary frequency, and to evaluate the efficacy of antimuscarinic treatment.Materials and Methods: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients complaining of persistent urinary frequency despite improved pain were evaluated. Before initial conventional treatment, each patient completed a voiding diary and symptom questionnaires. After conventional treatment, patients were divided according to the presence of pain and frequency. Improved pain was defined as lesser than 3 points in visual analogue scale, and persistent urinary frequency as >10 times/d. Risk factors for persistent frequency were identified through multivariate analysis. The efficacy of antimuscarinic treatment was assessed by the mean change of frequency.Results: Of 171 IC/BPS patients treated with conventional therapy, 132 had improved pain after 3 months, but 72 had persistent fre-quency (72 of 132, 54.5%). Patients with persistent frequency had lower voided volume (p=0.008), lower maximal flow rate (p<0.001), lower maximal bladder capacity (p=0.003), and more frequent micturition (p<0.001) at baseline compared to those with improved frequency. Patients who took antimuscarinic agents showed slightly decreased urinary frequency, from 14.6 times/d to 13.5 times/d (p=0.438) after 3 months of medication. No patients showed more than a 20% decrease in frequency with antimuscarinics.Conclusions: About half of the patients with IC/BPS showed persistent frequency, with poor voiding function identified as a risk factor; antimuscarinic treatment was not effective in these patients.https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-58-353.pdfAntimuscarinics; Epidemiology; Interstitial cystitis; Pain; Urine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Aram Kim Kyeong-Ok Hoe Jung Hyun Shin Myung-Soo Choo |
spellingShingle |
Aram Kim Kyeong-Ok Hoe Jung Hyun Shin Myung-Soo Choo Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment Investigative and Clinical Urology Antimuscarinics; Epidemiology; Interstitial cystitis; Pain; Urine |
author_facet |
Aram Kim Kyeong-Ok Hoe Jung Hyun Shin Myung-Soo Choo |
author_sort |
Aram Kim |
title |
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
title_short |
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
title_full |
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
title_fullStr |
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
title_full_unstemmed |
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
title_sort |
evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment |
publisher |
Korean Urological Association |
series |
Investigative and Clinical Urology |
issn |
2466-0493 2466-054X |
publishDate |
2017-09-01 |
description |
Purpose: To investigate the incidence and risk factors associated with persistent urinary frequency, and to evaluate the efficacy of antimuscarinic treatment.Materials and Methods: Interstitial cystitis/bladder pain syndrome (IC/BPS) patients complaining of persistent urinary frequency despite improved pain were evaluated. Before initial conventional treatment, each patient completed a voiding diary and symptom questionnaires. After conventional treatment, patients were divided according to the presence of pain and frequency. Improved pain was defined as lesser than 3 points in visual analogue scale, and persistent urinary frequency as >10 times/d. Risk factors for persistent frequency were identified through multivariate analysis. The efficacy of antimuscarinic treatment was assessed by the mean change of frequency.Results: Of 171 IC/BPS patients treated with conventional therapy, 132 had improved pain after 3 months, but 72 had persistent fre-quency (72 of 132, 54.5%). Patients with persistent frequency had lower voided volume (p=0.008), lower maximal flow rate (p<0.001), lower maximal bladder capacity (p=0.003), and more frequent micturition (p<0.001) at baseline compared to those with improved frequency. Patients who took antimuscarinic agents showed slightly decreased urinary frequency, from 14.6 times/d to 13.5 times/d (p=0.438) after 3 months of medication. No patients showed more than a 20% decrease in frequency with antimuscarinics.Conclusions: About half of the patients with IC/BPS showed persistent frequency, with poor voiding function identified as a risk factor; antimuscarinic treatment was not effective in these patients. |
topic |
Antimuscarinics; Epidemiology; Interstitial cystitis; Pain; Urine |
url |
https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-58-353.pdf |
work_keys_str_mv |
AT aramkim evaluationoftheincidenceandriskfactorsassociatedwithpersistentfrequencyininterstitialcystitisbladderpainsyndromeandtheefficacyofantimuscarinictreatment AT kyeongokhoe evaluationoftheincidenceandriskfactorsassociatedwithpersistentfrequencyininterstitialcystitisbladderpainsyndromeandtheefficacyofantimuscarinictreatment AT junghyunshin evaluationoftheincidenceandriskfactorsassociatedwithpersistentfrequencyininterstitialcystitisbladderpainsyndromeandtheefficacyofantimuscarinictreatment AT myungsoochoo evaluationoftheincidenceandriskfactorsassociatedwithpersistentfrequencyininterstitialcystitisbladderpainsyndromeandtheefficacyofantimuscarinictreatment |
_version_ |
1716779536738156544 |